Intra‐Aortic Balloon Pump: Overall and Temporal Trends of Comparative Effectiveness in a National Registry
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31372 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Ben Cohen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Belinson Hospital, Rabin Medical Center, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Intra-Aortic Balloon Pumping, Shock, Cardiogenic, Acute Coronary Syndrome, Practice Patterns, Physicians'. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Although the latest studies failed to prove the benefit of routine intra‐aortic balloon pump (IABP) use in patients with acute myocardial infarction (MI) presenting with cardiogenic shock, the benefit of IABP utilization in selected cases in “real world” practice is unknown.
Aims
We sought to follow temporal trends in IABP use in a real‐world cohort of acute coronary syndrome (ACS).
Methods
We evaluated IABP utilization and patient outcomes from the Acute Coronary Syndrome in Israel Survey (ACSIS) between the years 2000 and 2021. Temporal trends and outcomes with IABP at two time periods were set: early (before 2012) and late (after 2012).
Results
Out of 18,662 ACS patients, 3.7% received IABP. The rate of IABP use was 4.5% in the early period and decreased to ~2.5% in the late period ( p < 0.001). Patients treated with IABP in the early period had more frequently reduced ejection fraction (64.5% vs. 53.2%, p < 0.01) and presented mostly with ST‐elevation MI (71.0% vs. 62.4%, p = 0.04). Cardiogenic shock on admission and in‐hospital occurred equally in both periods (14.6% vs. 17.1%, p = 0.66; 42.8% vs. 41.9%, p = 0.90, respectively). Thirty‐day mortality and MACE were comparable between time periods (28% vs. 30.7%, p = 0.547; 43.6% vs. 44.1%, p = 0.978, respectively) however bleeding complications were significantly higher in the later period (4.8% vs. 11.2%, p = 0.04).
Conclusions
Our real‐world ACS data demonstrated a 50% reduction in the utilization of IABP among acute MI patients in the last decade. A comparable poor prognosis with IABP across time periods, suggest sustainable worse outcome in routine albeit selective clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Belinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
- The Faculty of Medicine at Tel Aviv University, Tel Aviv, Israel.
- Shamir Medical Center, Cardiology Institute, Tzrifin, Israel.
- Cardiology Department, Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel.
- Department of Cardiology, Sheba Medical Center, Ramat Gan, Israel.
- Israeli Center of Cardiovascular Research, Tel Hashomer, Israel.
ORCID-Profile: Leor Perl, Gabi Greenberg, Ran Kornowski, Katia Orvin
Zitieren
APA
Cohen, B., Kalmanovich, E., Perl, L., Greenberg, G., Beigel, R., Ovdat, T., Kornowski, R., & Orvin, K. (2025). Intra‐Aortic Balloon Pump: Overall and Temporal Trends of Comparative Effectiveness in a National Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31372
Vancouver
Cohen B, Kalmanovich E, Perl L, Greenberg G, Beigel R, Ovdat T, et al. Intra‐Aortic Balloon Pump: Overall and Temporal Trends of Comparative Effectiveness in a National Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31372
BibTeX
@article{Cohen2025,
author = {Cohen, Ben and Kalmanovich, Eran and Perl, Leor and Greenberg, Gabi and Beigel, Roy and Ovdat, Tal and Kornowski, Ran and Orvin, Katia},
title = {Intra‐Aortic Balloon Pump: Overall and Temporal Trends of Comparative Effectiveness in a National Registry},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31372}
}
EUVIMED